Site içinde arama yapın

Akash Motar bir ses eklendi Other
2025-12-12 13:59:51 -

Kirsten Rat Sarcoma (KRAS) Market: Targeted Therapies, Next-Generation Inhibitors (G12C), and Oncology Drug Development
"Executive Summary Kirsten Rat Sarcoma (KRAS) Market Size and Share: Global Industry Snapshot Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market report offers the most appropriate solution for the...

0 Yorumlar 0 hisse senetleri 627 Views 0 önizleme

Please log in to like, share and comment!
Akash Motar bir ses eklendi Other
2025-12-09 17:00:23 -

Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology Landscape
Executive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...

0 Yorumlar 0 hisse senetleri 722 Views 0 önizleme

Please log in to like, share and comment!
Ksh Dbmr bir ses eklendi Networking
2026-03-16 06:27:38 -

How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?
Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

0 Yorumlar 0 hisse senetleri 67 Views 0 önizleme

Please log in to like, share and comment!
Ksh Dbmr bir ses eklendi Networking
2026-03-16 06:40:15 -

What Breakthrough Drug Delivery Technologies Are Fueling the Peptide-Drug Conjugate Therapeutics Market?
Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...

0 Yorumlar 0 hisse senetleri 67 Views 0 önizleme

Please log in to like, share and comment!